Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07282834 · ClinicalTrials.gov registry record · Phase 2
Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)
A Phase 2 study of Peritoneal Carcinomatosis and Abdominal Cancer, sponsored by Patrick Wagner, MD, FACS.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07282834 is a Phase 2 study of Peritoneal Carcinomatosis and Abdominal Cancer that is actively recruiting participants, run by Patrick Wagner, MD, FACS. The registered enrollment target is 200 participants, above the 45-participant average among 14 other Peritoneal Carcinomatosis trials with a reported enrollment target (344% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07282834, a Phase 2 study of Peritoneal Carcinomatosis and Abdominal Cancer, is actively recruiting participants, sponsored by Patrick Wagner, MD, FACS.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study aims to improve the treatment of Peritoneal Carcinomatosis (PC), a condition where cancer spreads within the abdomen. Patients with PC often experience significant pain and nutritional problems. Currently, there isn't a standard treatment approach, and doctors use different combinations of chemotherapy, surgery, and methods to deliver chemotherapy directly into the abdomen (intra-peritoneal or "IP" chemotherapy). The study will compare two IP chemotherapy methods: HIPEC and PIPAC. HIPEC involves circulating heated chemotherapy through the abdomen during surgery, while PIPAC delivers chemotherapy as a pressurized aerosol during a laparoscopic procedure. Both methods aim to achieve the same goal, but they haven't been directly compared to see which is safer, more tolerable, more effective, and provides better value.
Conditions Studied
Interventions
- PROCEDURE Heated intra-peritoneal chemotherapy
- PROCEDURE Aerosolized intra-peritoneal chemotherapy
Study Locations (1)
Pennsylvania
- Allegheny Health Network West Penn Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-01-05 |
| Est. Completion | 2040-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07282834
The ClinicalTrials.gov registry entry for NCT07282834 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 45-participant average among 14 other Peritoneal Carcinomatosis trials with a reported enrollment target (344% higher). The listed sponsor is Patrick Wagner, MD, FACS, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Peritoneal Carcinomatosis appearing as the primary indexed condition, and to 2 interventions - of which Heated intra-peritoneal chemotherapy is the first listed.
NCT07282834 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07282834 about?
NCT07282834 is a clinical study titled "Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)". This research study aims to improve the treatment of Peritoneal Carcinomatosis (PC), a condition where cancer spreads within the abdomen. Patients with PC often experience significant pain and nutritional problems. Currently, there isn't a standard treatment approach, and doctors use different combi...
What is the current status of trial NCT07282834?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2026-01-05. Estimated completion is 2040-11.
What conditions does trial NCT07282834 study?
This clinical trial studies the following conditions: Peritoneal Carcinomatosis, Abdominal Cancer, Peritoneal (Metastatic) Cancer, Abdominal Cancer Patients.
What interventions are being tested in trial NCT07282834?
The interventions under investigation include: Heated intra-peritoneal chemotherapy (PROCEDURE), Aerosolized intra-peritoneal chemotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT07282834?
This trial is sponsored by Patrick Wagner, MD, FACS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07282834 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peritoneal Carcinomatosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
RECRUITING · Phase 2
-
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
RECRUITING · Phase 2
-
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
RECRUITING · Phase 2
-
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RECRUITING · Phase 2
-
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
RECRUITING · Phase 2
-
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.